CFO Michael Berry sold $1.8M worth of MDB at $351.11, reducing his directly held shares by 76.9% from a price 14.8% below the 90-day high. This major reduction of personal exposure is notable even against a STRONG BUY analyst consensus, as it may signal a belief the recent rally is mature. Bear: breaks the $292.72 30-day low support; bull holds above $351.

Where it could go — Broad base rate 41.7% positive at 90d; bear breaks $292.72, bull holds $351.

CFO Michael Berry sold $1.8M worth of MDB at $356.63, reducing his directly held stake by 43.5% from a position 14.6% below the 90-day high. As the CFO's first-ever transaction after a long tenure, this large, concentrated sale for personal liquidity introduces a new source of supply and questions about internal valuation. Bear: breaks $292.72.

Where it could go — Broad base rate 36.4% positive at 90d; bear breaks $292.72.

Director Dwight Merriman sold $5.6M worth of MDB shares at $352.04, reducing his direct holdings by 3.3% in another routine sale. This continues his established pattern of consistent selling with no buying history, though the stock trades 14.6% below its 90-day high with strong analyst consensus.

Where it could go — 26 similar MDB signals averaged +13.4% at 30d; watch $412 as resistance, $292 as support.

Director Ittycheria sold $15.3M of MDB at $383.16, reducing his stake by 19.8% while the stock traded just 7.0% below its 90-day high. This continues his established pattern of routine sales with no supporting insider buying activity despite the STRONG BUY analyst consensus.

Where it could go — Analyst mean target data unavailable; bear case if stock breaks below $255 support.

Director Botha Roelof bought $269K of MDB at $395.48, increasing his stake by just 0.3% after six previous sales. This isolated first-time buy lacks cluster support and represents minimal conviction compared to his recent $16M+ NTRA sales.

Where it could go — Analyst mean target unavailable; watch $412 as resistance, $255 as support given recent volatility.

Director Cochran sold $350K of MDB at $350, reducing stake by 3.6% near the stock's 90-day high. This appears to be routine diversification by a first-time seller with no supporting cluster buys amid strong analyst consensus.

Where it could go — Analyst mean target unavailable; bear case if stock breaks $244 support.

Director Dwight Merriman sold $260K worth of MDB shares at $293.18, reducing his stake by a negligible 0.1%. This second small sale in a week, with no other insiders buying, is typical diversification and not a strong directional signal.

Where it could go — Analyst mean target not provided; bear case if stock breaks the 90-day low of $215.68.

Director Dwight Merriman executed a Code-S open-market sale of 2,000 shares at $290.06 on 2026-05-07, reducing holdings from 1,005,316 to 1,003,316 shares (-0.2% stake delta, $580K value). This is Merriman's first Form 4 filing on record—no prior Code-P buys or Code-S sales exist, eliminating historical pattern comparison for this insider. The transaction occurred 25.2% below the 90-day high of $388.00 and 34.5% above the 90-day low of $215.68, with 46 analysts maintaining STRONG BUY consensus (36 buy / 10 hold / 0 sell) and earnings due 2026-05-28.

Where it could go — No comparable historical baseline exists for this insider's trading behavior; analyst consensus target range would be required to establish conditional directional thesis—if mean target implies >10% upside from $290.06, the sale timing near mid-range suggests portfolio rebalancing rather than conviction shift, invalidated only if stock breaks below the $215.68 90-day low.